Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0QZJQV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
39410752 ADC (11)
|
|||||
| Synonyms |
ADC (11)
Click to Show/Hide
|
|||||
| Organization |
Ajinomoto Co., Inc.; Ajinomoto Bio-Pharma Services.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
10.8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mc-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Site-specific bioconjugation at Trastuzumab-Lys248-thiol
|
|||||
| Combination Type |
Vedotin
|
|||||